- Johnson Johnson: Changing health for humanity
Johnson Johnson MedTech innovates at the intersection of biology and technology With a focus on treating with pinpoint precision in the hardest-to-reach parts of the body, restoring anatomy and reimagining healing, our portfolio of smarter, less invasive, more personalized treatments is addressing the most complex health challenges Healthcare areas include: Cardiovascular, Orthopaedics
- Investor Relations | Johnson Johnson
At Johnson Johnson, we believe health is everything Our strength in healthcare innovation empowers us to build a world where complex diseases are prevented, treated and cured, treatments are smarter and less invasive and solutions are personal
- Our company - Johnson Johnson
Every day, our more than 150,000 employees across the world are blending heart, science and ingenuity to profoundly change the trajectory of health for humanity
- Explore careers at Johnson Johnson | Johnson Johnson Careers
Elevate your career with J J Discover global job opportunities to drive innovation, impact lives and grow in a supportive, mission-driven culture
- Explore current job openings | Johnson Johnson Careers
Explore exciting job openings at J J Search global roles in healthcare and join a team committed to innovation, growth and a healthier future for all
- Healthcare products - Johnson Johnson
Johnson Johnson MedTech innovates at the intersection of biology and technology With a focus on treating with pinpoint precision in the hardest-to-reach parts of the body, restoring anatomy and reimagining healing, our portfolio of smarter, less invasive, more personalized treatments is addressing the most complex health challenges Healthcare areas include: Cardiovascular, Orthopaedics
- Locations | Johnson Johnson Careers
Learn about the regions and countries where J J operates and explore career opportunities, search for jobs and apply to join us wherever you are in the world
- Johnson Johnson reports Q4 and Full-Year 2025 results
NEW BRUNSWICK, N J -- (BUSINESS WIRE)-- Johnson Johnson (NYSE: JNJ) today announced results for fourth-quarter and full-year 2025 “2025 was a catapult year for Johnson Johnson, fueled by the strongest portfolio and pipeline in our history,” said Joaquin Duato, Chairman and Chief Executive Officer, Johnson Johnson “Last year kicked off a new era of accelerated growth, driven by
|